Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;33(5):837-845.
doi: 10.1007/s00467-017-3867-1. Epub 2017 Dec 20.

Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus

Chen-Xing Zhang  1   2 , Li Cai  1   2 , Kang Shao  3 , Jing Wu  2 , Wei Zhou  4 , Lan-Fang Cao  5 , Tong-Xin Chen  6   7   8
Affiliations

Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus

Chen-Xing Zhang et al. Pediatr Nephrol. 2018 May.

Abstract

Background: Traditional serological biomarkers often fail to assess systemic lupus erythematosus (SLE) disease activity and discriminate lupus nephritis (LN). The aim of this study was to identify novel markers for evaluating renal and overall disease activity in Chinese patients with pediatric systemic lupus erythematosus (pSLE).

Methods: The study included 46 patients with pSLE (35 girls, 11 boys; average age 13.3 ± 2.6 years) and 31 matched healthy controls (22 girls, 9 boys; average age 12.3 ± 2.4 years). The SLE Disease Activity Index (SLEDAI) and renal SLEDAI were used to assess disease activity. Nine different soluble mediators in plasma, including tumor necrosis factor alpha (TNF-α), platelet-derived growth factor-BB (PDGF-BB), interferon (IFN) gamma inducible protein 10 (IP-10), interleukin (IL)-1β, IFN-γ, IL-17A, IL-2, Fas and Fas ligand, were measured by Luminex assay and compared between patients with active and inactive pSLE as well as between patients with pSLE with active and inactive renal disease. Receiver operating characteristic curve analysis was used to measure the discrimination accuracy.

Results: Of the 46 patients with pSLE, 30 (65.2%) had LN. These patients had significantly elevated levels of serum TNF-α, PDGF-BB, IP-10 and Fas. The serum levels of IP-10 were also significantly higher in patients with active pSLE. We found that IP-10 was also more sensitive and specific than conventional laboratory parameters, including anti-double-stranded DNA and complement components C3 and C4, for distinguishing active lupus from quiescent lupus. The serum level of IP-10 was also significantly increased in children with pSLE with active renal disease relative to those with inactive renal disease. There was also a positive correlation between serum IP-10 levels and renal SLEDAI scores as well as with 24 h urine protein.

Conclusions: Serum IP-10 is useful for identifying renal and overall disease activity in children with pSLE.

Keywords: Active renal disease; Clinical disease activity; IP-10; Pediatric systemic lupus erythematosus.

PubMed Disclaimer

References

    1. Arthritis Rheum. 1997 Sep;40(9):1725 - PubMed
    1. Pediatr Nephrol. 2017 Feb;32(2):283-295 - PubMed
    1. Hum Immunol. 2015 Aug;76(8):533-6 - PubMed
    1. Lupus. 2009 Oct;18(11):974-9 - PubMed
    1. Cytokine Growth Factor Rev. 1997 Sep;8(3):207-19 - PubMed

Publication types

LinkOut - more resources